Novus Therapeutics, Inc. 4
4 · Novus Therapeutics, Inc. · Filed Jul 10, 2017
Insider Transaction Report
Form 4
Kuwahara Jon
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-07-10+35,000→ 35,000 totalExercise: $5.61Exp: 2027-07-10→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 35,000 shares of the Issuer's Common Stock one quarter of which will become fully vested and exercisable on 7/10/2018, with the remaining 26,250 shares vesting in equal quarterly installments over the following three years.